Literature DB >> 2570960

Tumour necrosis factor in bronchopulmonary secretions of patients with adult respiratory distress syndrome.

A B Millar1, N M Foley, M Singer, N M Johnson, A Meager, G A Rook.   

Abstract

Tumour necrosis factor (TNF) concentrations were measured in the bronchopulmonary secretions of 5 patients with the adult respiratory distress syndrome. Each patient underwent fibreoptic bronchoscopy and bronchopulmonary aspiration, and control samples were obtained in an identical manner from 24 patients who underwent bronchoscopy for other reasons (8 had tuberculosis, 6 had sarcoidosis, and 10 had haemoptysis but no abnormal findings). Aspirated fluid was assayed for the presence of TNF by use of an enzyme-linked immunosorbent assay. In the 5 patients with adult respiratory distress syndrome, TNF concentrations exceeded 500 U/ml (12.5 ng/ml), whereas in the control samples no TNF was detected.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2570960     DOI: 10.1016/s0140-6736(89)90772-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  37 in total

Review 1.  Clinical implications of tumour necrosis factor alpha antagonism in patients with congestive heart failure.

Authors:  G Torre-Amione; S S Stetson; J A Farmer
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

Review 2.  Activation of cytokines as a mechanism of disease progression in heart failure.

Authors:  B Bozkurt
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

3.  Crohn's disease.

Authors:  S Murch; J A Walker-Smith
Journal:  Arch Dis Child       Date:  1991-04       Impact factor: 3.791

Review 4.  Immunological perspectives in prevention and treatment of nosocomial pneumonia.

Authors:  J E Pennington
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

5.  Elevated cytokine levels in tracheobronchial aspirate fluids from ventilator treated neonates with bronchopulmonary dysplasia.

Authors:  K Tullus; G W Noack; L G Burman; R Nilsson; B Wretlind; A Brauner
Journal:  Eur J Pediatr       Date:  1996-02       Impact factor: 3.183

6.  Sevoflurane reduces severity of acute lung injury possibly by impairing formation of alveolar oedema.

Authors:  M Schläpfer; A C Leutert; S Voigtsberger; R A Lachmann; C Booy; B Beck-Schimmer
Journal:  Clin Exp Immunol       Date:  2012-04       Impact factor: 4.330

7.  Surfactant administration prior to one lung ventilation: physiological and inflammatory correlates in a piglet model.

Authors:  Rahul Bhatia; Thomas H Shaffer; Jobayer Hossain; Alicia Olivant Fisher; Liana M Horner; M Elena Rodriguez; Scott Penfil; Mary C Theroux
Journal:  Pediatr Pulmonol       Date:  2011-05-26

Review 8.  Role of tumour necrosis factor-alpha in the progression of heart failure: therapeutic implications.

Authors:  G Torre-Amione; M T Vooletich; J A Farmer
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

9.  Effect of tumor necrosis factor receptor binding protein on cell infiltration induced by lipopolysaccharide and Sephadex beads in guinea pig lung.

Authors:  D M Conroy; J N Francischi; P Sirois
Journal:  Inflammation       Date:  1995-04       Impact factor: 4.092

10.  High levels of interleukin-8 in the blood and alveolar spaces of patients with pneumonia and adult respiratory distress syndrome.

Authors:  S Chollet-Martin; P Montravers; C Gibert; C Elbim; J M Desmonts; J Y Fagon; M A Gougerot-Pocidalo
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.